Dr. Robbins is an Adjunct Professor in the Department of Pharmacology and an Adjunct Associate Professor in the Department of Experimental and Clinical Pharmacology (ECP). He received his B.S. degree in Biochemistry from UCLA and his Ph.D. in Pharmacology from the University of Minnesota Medical School. He completed his postdoctoral training under Drs. Robert Sorenson and Robert Elde, in the Department of Anatomy at the University of Minnesota Medical School. Following his scientific training, Mark obtained a J.D. degree magna cum laude from Saint Louis University School of Law. Mark has over 35 years of broad-based drug research and development and commercialization experience in both start-up and fully integrated pharmaceutical/biotechnology companies. His therapeutic areas of interest include CNS, cardiovascular, oncology, endocrine/metabolic, women’s heath, and diagnostic medicine. He provides strategic assistance to entrepreneurs with starting up and financing biotech ventures. Mark is President of Kodiak Strategic Consultants, which assists in developing and implementing regulatory/clinical strategies leading to successful NDA/BLA approvals.
Links to Selected Published Works:
https://www.ncbi.nlm.nih.gov/pubmed/27165535 PMID: 27165535
https://www.ncbi.nlm.nih.gov/pubmed/26038695 PMID: 26038695
https://www.ncbi.nlm.nih.gov/pubmed/25259810 PMID:25259810
https://www.ncbi.nlm.nih.gov/pubmed/25100328 PMID: 25100328
Specialty
Graduate Faculty - Molecular Pharmacology and Therapeutics (MPaT)
